Latest Abbott Laboratories Stories
PARSIPPANY, N.J., March 19, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Niacin Extended-release Tablets, 500 mg and 1000 mg. Watson's ANDA products are generic versions of Abbott Laboratories' NIASPAN®. Abbott Laboratories and Abbott Respiratory LLC filed suit...
ABBOTT PARK, Ill., March 7, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Barclays Capital 2012 Global Healthcare Conference on Wednesday, March 14, 2012. John M. Leonard, M.D., senior vice president, pharmaceuticals, research and development, will make a formal presentation on the company's proprietary pharmaceutical pipeline at 1:30 p.m. Central time. A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at...
PARSIPPANY, N.J., March 2, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that Watson has launched an authorized generic version of PROMETRIUM® (progesterone, USP) Capsules 100mg and 200mg, as part of an agreement with Abbott Laboratories. Watson began shipping the product today. PROMETRIUM® Capsules are indicated for use in the prevention of endometrial hyperplasia in non hysterectomized postmenopausal women who are receiving conjugated estrogen...
ABBOTT PARK, Ill., March 2, 2012 /PRNewswire/ -- As part of a series of strategic moves to build its laboratory information management system (LIMS) business in Europe and emerging markets in Latin America and Africa, STARLIMS Technologies (http://www.starlims.com), an Abbott (NYSE: ABT) company, has announced the acquisition of several longtime distribution partners. These acquisitions include STARLIMS's French distributor Varilab; operations of two privately held Spanish...
ABBOTT PARK, Ill., March 1, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today announced plans to build a nutrition manufacturing facility in Tipp City, Ohio, to produce two of the company's fastest-growing adult brands, Ensure® and Glucerna®, for the North America market. Abbott will invest $270 million in the facility and will employ approximately 240 people. Groundbreaking is expected in April with the plant operational in late 2013. "As the U.S. population continues to age,...
ABBOTT PARK, Ill., Feb. 23, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a presentation on the company at 10:20 a.m. Central time. A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com. An archived edition of the...
In Jan 25th 2012, Abbott Laboratories (the company manufacturing Depakote) reported that 2011 selling, general and administrative expense report includes $1.5 billion of litigation reserves related to ongoing settlement discussions in the investigation by the U.S. Department of Justice, through the U.S. Attorney for the Western District of Virginia, related to Depakote. Depakote is a drug most commonly prescribed for psychiatric conditions like manic depressive disorder (bipolar disorder)...
ABBOTT PARK, Ill., Jan. 25, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2011. Diluted earnings per share, excluding specified items, were $1.45, at the high end of Abbott's previous guidance range, reflecting 11.5 percent growth. Diluted earnings per share under Generally Accepted Accounting Principles (GAAP) were $1.02, including specified items. Worldwide sales increased 4.1 percent to $10.4 billion, including a...
ABBOTT PARK, Ill. and URBANA, Ill., Dec. 19, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) and the University of Illinois at Urbana-Champaign announced today they have established the first-ever multi-disciplinary nutrition and cognition research center, which will be located on the Urbana campus. The Center for Nutrition, Learning, and Memory will lead directed and solicited research on the impact of nutrition on learning and memory in the human brain. The collaboration between...
CHICAGO, Dec. 8, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Pfizer (NYSE: PFE), Bristol - Myers Squibb (NYSE: BMY), Eli Lilly (NYSE: LLY), Forest Laboratories (NYSE: FRX) and Abbott Laboratories (NYSE: ABT). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) Get the...
